NCT03951194View on ClinicalTrials.gov

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

January 30, 2025

Study Completion Date

July 30, 2025

Conditions
Infertility, FemalePerimenopausal DisorderMenstrual Cycle Abnormal
Interventions
BIOLOGICAL

Autologous Platelet Rich Plasma (PRP) intra ovarian infusion

Autologous PRP intra ovarian infusion

OTHER

Placebo: Autologous Platelet Free Plasma (PFP) intra ovarian infusion

Autologous PFP intra ovarian infusion

Trial Locations (1)

15232

RECRUITING

Genesis AC, Athens

All Listed Sponsors
collaborator

National and Kapodistrian University of Athens

OTHER

lead

Genesis Athens Clinic

OTHER